25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Evelo Biosciences Inc
Buy, Hold or Sell?

Let's analyze Evelo Biosciences Inc together

I guess you are interested in Evelo Biosciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Evelo Biosciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Evelo Biosciences Inc

I send you an email if I find something interesting about Evelo Biosciences Inc.

1. Quick Overview

1.1. Quick analysis of Evelo Biosciences Inc (30 sec.)










1.2. What can you expect buying and holding a share of Evelo Biosciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.26
Expected worth in 1 year
$-3.14
How sure are you?
42.9%

+ What do you gain per year?

Total Gains per Share
$-2.88
Return On Investment
-575,636.9%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.0004 - $0.0015
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Evelo Biosciences Inc (5 min.)




Live pricePrice per Share (EOD)
$0.00
Intrinsic Value Per Share
$-65.40 - $-57.29
Total Value Per Share
$-65.67 - $-57.55

2.2. Growth of Evelo Biosciences Inc (5 min.)




Is Evelo Biosciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$4.9m$8.6m-$13.6m-273.6%

How much money is Evelo Biosciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$114.5m-$122.1m$7.6m6.7%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Evelo Biosciences Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Evelo Biosciences Inc?

Welcome investor! Evelo Biosciences Inc's management wants to use your money to grow the business. In return you get a share of Evelo Biosciences Inc.

First you should know what it really means to hold a share of Evelo Biosciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Evelo Biosciences Inc is $0.0005. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Evelo Biosciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Evelo Biosciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.26. Based on the TTM, the Book Value Change Per Share is $-0.72 per quarter. Based on the YOY, the Book Value Change Per Share is $-1.15 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Evelo Biosciences Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-6.03-1,206,639.7%-6.03-1,206,639.7%-6.44-1,287,228.4%-5.02-1,004,538.8%-3.96-791,442.8%
Usd Book Value Change Per Share-0.72-143,909.2%-0.72-143,909.2%-1.15-229,871.3%-0.36-72,476.1%-0.04-7,513.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.72-143,909.2%-0.72-143,909.2%-1.15-229,871.3%-0.36-72,476.1%-0.04-7,513.6%
Usd Price Per Share1.61-1.61-6.07-7.37-5.26-
Price to Earnings Ratio-0.27--0.27--0.94--1.72--1.23-
Price-to-Total Gains Ratio-2.24--2.24--5.28--2.79--2.79-
Price to Book Ratio-6.12--6.12-13.29-3.56-2.54-
Price-to-Total Gains Ratio-2.24--2.24--5.28--2.79--2.79-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0005
Number of shares2000000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.72-0.36
Usd Total Gains Per Share-0.72-0.36
Gains per Quarter (2000000 shares)-1,439,092.23-724,761.36
Gains per Year (2000000 shares)-5,756,368.92-2,899,045.45
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-5756369-57563790-2899045-2899055
20-11512738-115127480-5798091-5798100
30-17269107-172691170-8697136-8697145
40-23025476-230254860-11596182-11596190
50-28781845-287818550-14495227-14495235
60-34538214-345382240-17394273-17394280
70-40294582-402945930-20293318-20293325
80-46050951-460509620-23192364-23192370
90-51807320-518073310-26091409-26091415
100-57563689-575637000-28990455-28990460

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.07.00.00.0%0.07.00.00.0%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%3.04.00.042.9%3.04.00.042.9%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.07.00.0%0.00.07.00.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%3.04.00.042.9%3.04.00.042.9%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Evelo Biosciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.720-0.7200%-1.149+60%-0.362-50%-0.038-95%
Book Value Per Share---0.263-0.2630%0.457-158%2.437-111%2.004-113%
Current Ratio--4.1614.1610%4.091+2%7.146-42%7.546-45%
Debt To Asset Ratio--1.0771.0770%0.901+20%0.625+72%0.594+82%
Debt To Equity Ratio----0%9.139-100%2.358-100%2.091-100%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--9069308.0009069308.0000%104462596.000-91%169576870.400-95%169576870.400-95%
Eps---6.033-6.0330%-6.436+7%-5.023-17%-3.957-34%
Ev To Ebitda Ratio---0.085-0.0850%-0.905+961%-2.346+2651%-2.346+2651%
Ev To Sales Ratio--infinfnan%infnan%infnan%infnan%
Free Cash Flow Per Share---5.366-5.3660%-5.175-4%-4.238-21%-3.317-38%
Free Cash Flow To Equity Per Share---1.064-1.0640%-0.037-97%0.099-1172%0.268-498%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---57.287--------
Intrinsic Value_10Y_min---65.403--------
Intrinsic Value_1Y_max---4.572--------
Intrinsic Value_1Y_min---5.311--------
Intrinsic Value_3Y_max---14.628--------
Intrinsic Value_3Y_min---17.128--------
Intrinsic Value_5Y_max---25.757--------
Intrinsic Value_5Y_min---30.138--------
Market Cap9491.400-321900%30562308.00030562308.0000%115225596.000-73%139865270.400-78%99903764.571-69%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio-0.002+100%-6.122-6.1220%13.295-146%3.557-272%2.541-341%
Pe Ratio0.000+100%-0.267-0.2670%-0.943+253%-1.724+546%-1.231+361%
Price Per Share0.001-321900%1.6101.6100%6.070-73%7.368-78%5.263-69%
Price To Free Cash Flow Ratio0.000+100%-0.300-0.3000%-1.173+291%-2.054+584%-1.467+389%
Price To Total Gains Ratio-0.001+100%-2.238-2.2380%-5.281+136%-2.790+25%-2.790+25%
Quick Ratio--3.8683.8680%3.942-2%8.245-53%8.300-53%
Return On Assets---1.777-1.7770%-1.390-22%-1.096-38%-0.977-45%
Return On Equity----0%-14.0970%-3.7970%-3.1930%
Total Gains Per Share---0.720-0.7200%-1.149+60%-0.362-50%-0.038-95%
Usd Book Value---4992000.000-4992000.0000%8667000.000-158%46261200.000-111%38033571.429-113%
Usd Book Value Change Per Share---0.720-0.7200%-1.149+60%-0.362-50%-0.038-95%
Usd Book Value Per Share---0.263-0.2630%0.457-158%2.437-111%2.004-113%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--9069308.0009069308.0000%104462596.000-91%169576870.400-95%169576870.400-95%
Usd Eps---6.033-6.0330%-6.436+7%-5.023-17%-3.957-34%
Usd Free Cash Flow---101857000.000-101857000.0000%-98244000.000-4%-80447600.000-21%-62972714.286-38%
Usd Free Cash Flow Per Share---5.366-5.3660%-5.175-4%-4.238-21%-3.317-38%
Usd Free Cash Flow To Equity Per Share---1.064-1.0640%-0.037-97%0.099-1172%0.268-498%
Usd Market Cap9491.400-321900%30562308.00030562308.0000%115225596.000-73%139865270.400-78%99903764.571-69%
Usd Price Per Share0.001-321900%1.6101.6100%6.070-73%7.368-78%5.263-69%
Usd Profit---114527000.000-114527000.0000%-122176000.000+7%-93977000.000-18%-73037714.286-36%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.720-0.7200%-1.149+60%-0.362-50%-0.038-95%
 EOD+2 -6MRQTTM+0 -0YOY+13 -185Y+5 -2610Y+5 -26

3.3 Fundamental Score

Let's check the fundamental score of Evelo Biosciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-150.000
Price to Book Ratio (EOD)Between0-1-0.002
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than13.868
Current Ratio (MRQ)Greater than14.161
Debt to Asset Ratio (MRQ)Less than11.077
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-1.777
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Evelo Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.781
Ma 20Greater thanMa 500.001
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.001
OpenGreater thanClose0.001
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Evelo Biosciences Inc

Evelo Biosciences, Inc., a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis. The company is also developing EDP1867, a non-live pharmaceutical preparation for single strain of Veillonella parvula, which is in Phase 1b clinical trial; EDP2939, an investigational oral biologic for the potential treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

Fundamental data was last updated by Penke on 2024-12-02 09:45:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Evelo Biosciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Evelo Biosciences Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Evelo Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--108.0%+108.0%
TTM--218.6%+218.6%
YOY--210.1%+210.1%
5Y--339.1%+339.1%
10Y--464.5%+464.5%
4.3.1.2. Return on Assets

Shows how efficient Evelo Biosciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Evelo Biosciences Inc to the Biotechnology industry mean.
  • -177.7% Return on Assets means that Evelo Biosciences Inc generated $-1.78 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Evelo Biosciences Inc:

  • The MRQ is -177.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -177.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-177.7%TTM-177.7%0.0%
TTM-177.7%YOY-139.0%-38.7%
TTM-177.7%5Y-109.6%-68.1%
5Y-109.6%10Y-97.7%-11.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-177.7%-11.3%-166.4%
TTM-177.7%-11.8%-165.9%
YOY-139.0%-11.3%-127.7%
5Y-109.6%-12.6%-97.0%
10Y-97.7%-14.2%-83.5%
4.3.1.3. Return on Equity

Shows how efficient Evelo Biosciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Evelo Biosciences Inc to the Biotechnology industry mean.
  • 0.0% Return on Equity means Evelo Biosciences Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Evelo Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-1,409.7%+1,409.7%
TTM-5Y-379.7%+379.7%
5Y-379.7%10Y-319.3%-60.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--14.2%+14.2%
TTM--15.9%+15.9%
YOY-1,409.7%-14.4%-1,395.3%
5Y-379.7%-18.5%-361.2%
10Y-319.3%-19.5%-299.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Evelo Biosciences Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Evelo Biosciences Inc is operating .

  • Measures how much profit Evelo Biosciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Evelo Biosciences Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Evelo Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--204.6%+204.6%
TTM--313.2%+313.2%
YOY--219.0%+219.0%
5Y--388.9%+388.9%
10Y--495.6%+495.6%
4.3.2.2. Operating Ratio

Measures how efficient Evelo Biosciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Evelo Biosciences Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.340-2.340
TTM-3.187-3.187
YOY-3.282-3.282
5Y-4.814-4.814
10Y-6.494-6.494
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Evelo Biosciences Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Evelo Biosciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.16 means the company has $4.16 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Evelo Biosciences Inc:

  • The MRQ is 4.161. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.161. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.161TTM4.1610.000
TTM4.161YOY4.091+0.070
TTM4.1615Y7.146-2.985
5Y7.14610Y7.546-0.400
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1613.645+0.516
TTM4.1613.883+0.278
YOY4.0914.666-0.575
5Y7.1465.964+1.182
10Y7.5466.265+1.281
4.4.3.2. Quick Ratio

Measures if Evelo Biosciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Evelo Biosciences Inc to the Biotechnology industry mean.
  • A Quick Ratio of 3.87 means the company can pay off $3.87 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Evelo Biosciences Inc:

  • The MRQ is 3.868. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.868. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.868TTM3.8680.000
TTM3.868YOY3.942-0.074
TTM3.8685Y8.245-4.377
5Y8.24510Y8.300-0.055
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.8683.014+0.854
TTM3.8683.418+0.450
YOY3.9424.456-0.514
5Y8.2455.970+2.275
10Y8.3006.424+1.876
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Evelo Biosciences Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Evelo Biosciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Evelo Biosciences Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.08 means that Evelo Biosciences Inc assets are financed with 107.7% credit (debt) and the remaining percentage (100% - 107.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Evelo Biosciences Inc:

  • The MRQ is 1.077. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 1.077. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.077TTM1.0770.000
TTM1.077YOY0.901+0.176
TTM1.0775Y0.625+0.453
5Y0.62510Y0.594+0.031
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0770.350+0.727
TTM1.0770.341+0.736
YOY0.9010.310+0.591
5Y0.6250.365+0.260
10Y0.5940.382+0.212
4.5.4.2. Debt to Equity Ratio

Measures if Evelo Biosciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Evelo Biosciences Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Evelo Biosciences Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY9.139-9.139
TTM-5Y2.358-2.358
5Y2.35810Y2.091+0.267
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.394-0.394
TTM-0.432-0.432
YOY9.1390.380+8.759
5Y2.3580.451+1.907
10Y2.0910.490+1.601
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Evelo Biosciences Inc generates.

  • Above 15 is considered overpriced but always compare Evelo Biosciences Inc to the Biotechnology industry mean.
  • A PE ratio of -0.27 means the investor is paying $-0.27 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Evelo Biosciences Inc:

  • The EOD is 0.000. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.267. Based on the earnings, the company is expensive. -2
  • The TTM is -0.267. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD0.000MRQ-0.267+0.267
MRQ-0.267TTM-0.2670.000
TTM-0.267YOY-0.943+0.676
TTM-0.2675Y-1.724+1.457
5Y-1.72410Y-1.231-0.492
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.000-2.315+2.315
MRQ-0.267-2.491+2.224
TTM-0.267-3.156+2.889
YOY-0.943-3.274+2.331
5Y-1.724-6.037+4.313
10Y-1.231-6.785+5.554
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Evelo Biosciences Inc:

  • The EOD is 0.000. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.300. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.300. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD0.000MRQ-0.300+0.300
MRQ-0.300TTM-0.3000.000
TTM-0.300YOY-1.173+0.873
TTM-0.3005Y-2.054+1.754
5Y-2.05410Y-1.467-0.587
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.000-2.985+2.985
MRQ-0.300-3.361+3.061
TTM-0.300-3.734+3.434
YOY-1.173-4.557+3.384
5Y-2.054-8.327+6.273
10Y-1.467-9.311+7.844
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Evelo Biosciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -6.12 means the investor is paying $-6.12 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Evelo Biosciences Inc:

  • The EOD is -0.002. Based on the equity, the company is expensive. -2
  • The MRQ is -6.122. Based on the equity, the company is expensive. -2
  • The TTM is -6.122. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.002MRQ-6.122+6.120
MRQ-6.122TTM-6.1220.000
TTM-6.122YOY13.295-19.417
TTM-6.1225Y3.557-9.679
5Y3.55710Y2.541+1.016
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.0021.919-1.921
MRQ-6.1222.051-8.173
TTM-6.1222.374-8.496
YOY13.2952.454+10.841
5Y3.5573.737-0.180
10Y2.5414.378-1.837
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Evelo Biosciences Inc.

4.8.1. Institutions holding Evelo Biosciences Inc

Institutions are holding 12.854% of the shares of Evelo Biosciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30Flagship Ventures Management, Inc.41.78842.257179326245411255214.6158
2023-09-30Alyeska Investment Group, L.P.1.39650.00712651032651030
2023-12-31Acadian Asset Management LLC0.2517047775477750
2023-12-31XTX Topco Ltd0.05370.000110189101890
2023-09-30Daiwa Securities Group Inc00700
2023-12-31Susquehanna International Group, LLP000-26679-100
2023-12-31Wells Fargo & Co000-52-100
2023-12-31Tower Research Capital LLC000-3453-100
2023-12-31Northern Trust Corp000-18200-100
2023-12-31Barclays PLC000-11755-100
2023-12-31Millennium Management LLC000-38093-100
2023-12-31Harbourvest Partners, LLC000-1451876-100
2023-12-31State Treasurer State Of Michigan000-203536-100
2023-12-31Morgan Stanley - Brokerage Accounts000-22765-100
2023-12-31Credit Suisse First Boston (CSFB)000-200000-100
2023-12-31Alphabet Inc000-53024-100
2023-09-30Advisor Group Holdings, Inc.000-75-100
2023-12-31Royal Bank of Canada000-505-100
2023-12-31FMR Inc000-2446390-100
2023-12-31Citigroup Inc000-1872-100
Total 43.49032.26438255698+1256047+15.2%

4.9.2. Funds holding Evelo Biosciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30BlackRock Extended Mkt Composite0.13310.00072527221775622.6766
2023-10-31Vanguard Instl Ttl Stck Mkt Idx Tr0.014502747-101801-97.3725
2023-12-31GF NASDAQ Bio-Tech Idx QDII RMB A0.00180.00013473373370
2024-01-31JHVIT Total Stock Market Index I0.0007012900
2023-06-30China Universal NASDAQ Bio-Tch ETF(QDII)00.0017721628.5714
Total 0.15010.002528567-79673-278.9%

5.3. Insider Transactions

Insiders are holding 0.136% of the shares of Evelo Biosciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-11-08Marella ThorellSELL18110.33
2023-11-08Mark BodmerSELL31630.33
2023-11-08Simba GillSELL1720.33
2023-09-28Simba GillSELL19963.94
2023-08-08Marella ThorellSELL20049.51
2023-08-08Mark BodmerSELL31289.51
2023-08-08Simba GillSELL3429.51
2023-07-11Ventures Fund Iv Gene FlagshipBUY54112552.31
2023-05-23Mark BodmerSELL11282.8
2023-05-08Duncan MchaleSELL33362.6
2023-05-08Marella ThorellSELL19262.6
2023-05-08Simba GillSELL1762.6
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Total Stockholder Equity 136,949-76,75260,197-29,71230,485-21,8188,667-13,659-4,992
Net Debt  -135,61477,415-58,19929,379-28,82016,672-12,14815,3463,198
Net Tangible Assets  136,949-76,75260,197-29,71230,485-21,8188,667-13,659-4,992



5.2. Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets64,441
Total Liabilities69,433
Total Stockholder Equity-4,992
 As reported
Total Liabilities 69,433
Total Stockholder Equity+ -4,992
Total Assets = 64,441

Assets

Total Assets64,441
Total Current Assets51,573
Long-term Assets12,868
Total Current Assets
Cash And Cash Equivalents 47,940
Other Current Assets 3,633
Total Current Assets  (as reported)51,573
Total Current Assets  (calculated)51,573
+/-0
Long-term Assets
Property Plant Equipment 11,710
Other Assets 1,158
Long-term Assets  (as reported)12,868
Long-term Assets  (calculated)12,868
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities12,395
Long-term Liabilities57,038
Total Stockholder Equity-4,992
Total Current Liabilities
Short-term Debt 2,259
Accounts payable 1,764
Other Current Liabilities 872
Total Current Liabilities  (as reported)12,395
Total Current Liabilities  (calculated)4,895
+/- 7,500
Long-term Liabilities
Long term Debt 43,614
Capital Lease Obligations Min Short Term Debt5,265
Other Liabilities 8,159
Long-term Liabilities Other 659
Long-term Liabilities  (as reported)57,038
Long-term Liabilities  (calculated)57,697
+/- 659
Total Stockholder Equity
Common Stock111
Retained Earnings -529,222
Other Stockholders Equity 524,119
Total Stockholder Equity (as reported)-4,992
Total Stockholder Equity (calculated)-4,992
+/-0
Other
Capital Stock111
Cash and Short Term Investments 47,940
Common Stock Shares Outstanding 4,358
Current Deferred Revenue7,500
Liabilities and Stockholders Equity 64,441
Net Debt 3,198
Net Invested Capital 38,622
Net Tangible Assets -4,992
Net Working Capital 39,178
Property Plant and Equipment Gross 11,710
Short Long Term Debt Total 51,138



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
18,570
43,788
159,867
90,920
90,639
87,871
64,441
64,44187,87190,63990,920159,86743,78818,570
   > Total Current Assets 
15,720
38,777
147,919
77,833
68,857
71,026
51,573
51,57371,02668,85777,833147,91938,77715,720
       Cash And Cash Equivalents 
15,536
38,246
147,919
77,833
68,857
68,441
47,940
47,94068,44168,85777,833147,91938,24615,536
       Short-term Investments 
0
0
54,818
0
0
0
0
000054,81800
       Other Current Assets 
184
531
3,703
3,176
2,123
2,585
3,633
3,6332,5852,1233,1763,703531184
   > Long-term Assets 
2,850
5,011
11,948
13,087
21,782
16,845
12,868
12,86816,84521,78213,08711,9485,0112,850
       Property Plant Equipment 
2,504
3,496
6,925
8,341
18,235
15,532
11,710
11,71015,53218,2358,3416,9253,4962,504
       Other Assets 
346
1,515
1,320
1,570
12,181
1,313
1,158
1,1581,31312,1811,5701,3201,515346
> Total Liabilities 
13,044
14,385
22,918
30,723
60,154
79,204
69,433
69,43379,20460,15430,72322,91814,38513,044
   > Total Current Liabilities 
2,248
3,839
9,235
9,743
19,833
17,362
12,395
12,39517,36219,8339,7439,2353,8392,248
       Short-term Debt 
9,931
9,966
0
0
1,674
3,902
2,259
2,2593,9021,674009,9669,931
       Short Long Term Debt 
9,931
9,966
0
0
0
0
0
000009,9669,931
       Accounts payable 
637
1,411
9,235
620
1,442
1,601
1,764
1,7641,6011,4426209,2351,411637
       Other Current Liabilities 
1,611
2,428
7,716
9,123
18,391
-7,043
872
872-7,04318,3919,1237,7162,4281,611
   > Long-term Liabilities 
10,796
10,546
13,683
20,980
40,321
61,842
57,038
57,03861,84240,32120,98013,68310,54610,796
       Long term Debt Total 
9,931
9,966
12,305
19,634
30,048
46,557
0
046,55730,04819,63412,3059,9669,931
       Other Liabilities 
742
580
1,378
1,346
284
7,500
8,159
8,1597,5002841,3461,378580742
       Deferred Long Term Liability 
0
0
1,071
1,148
0
7,500
0
07,50001,1481,07100
> Total Stockholder Equity
5,526
29,403
136,949
60,197
30,485
8,667
-4,992
-4,9928,66730,48560,197136,94929,4035,526
   Common Stock
4
20
32
32
47
54
111
11154473232204
   Retained Earnings Total Equity0-414,695-292,519-198,853-113,38100
   Accumulated Other Comprehensive Income 000-90,920-18-1,429-595
   Capital Surplus 
0
1,684
250,316
259,018
322,957
423,308
0
0423,308322,957259,018250,3161,6840
   Treasury Stock0000000
   Other Stockholders Equity 
595
87,223
90,449
259,018
322,957
423,308
524,119
524,119423,308322,957259,01890,44987,223595



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-74,335
Operating Income-74,335-74,335
 
Operating Expense (+$)
Research Development53,483
Selling General Administrative20,852
Selling And Marketing Expenses-
Operating Expense74,33574,335
 
Net Interest Income (+$)
Interest Income-
Interest Expense-5,479
Other Finance Cost-0
Net Interest Income-5,479
 
Pretax Income (+$)
Operating Income-74,335
Net Interest Income-5,479
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-81,444-72,705
EBIT - interestExpense = -5,479
-82,349
-76,870
Interest Expense5,479
Earnings Before Interest and Taxes (EBIT)--75,965
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-81,444
Tax Provision-905
Net Income From Continuing Ops-82,349-82,349
Net Income-82,349
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-1,6305,479
 

Technical Analysis of Evelo Biosciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Evelo Biosciences Inc. The general trend of Evelo Biosciences Inc is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Evelo Biosciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Evelo Biosciences Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.0015 < 0.0015 < 0.0015.

The bearish price targets are: 0.0004 > 0.0004 > 0.0004.

Tweet this
Evelo Biosciences Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Evelo Biosciences Inc. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Evelo Biosciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Evelo Biosciences Inc. The current macd is -0.000017.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Evelo Biosciences Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Evelo Biosciences Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Evelo Biosciences Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Evelo Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartEvelo Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Evelo Biosciences Inc. The current adx is 7.9588513.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Evelo Biosciences Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Evelo Biosciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Evelo Biosciences Inc. The current sar is 0.00704001.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Evelo Biosciences Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Evelo Biosciences Inc. The current rsi is 48.78. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Evelo Biosciences Inc Daily Relative Strength Index (RSI) ChartEvelo Biosciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Evelo Biosciences Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Evelo Biosciences Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Evelo Biosciences Inc Daily Stochastic Oscillator ChartEvelo Biosciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Evelo Biosciences Inc. The current cci is -22.42609582.

Evelo Biosciences Inc Daily Commodity Channel Index (CCI) ChartEvelo Biosciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Evelo Biosciences Inc. The current cmo is -3.33753608.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Evelo Biosciences Inc Daily Chande Momentum Oscillator (CMO) ChartEvelo Biosciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Evelo Biosciences Inc. The current willr is -83.33333333.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Evelo Biosciences Inc Daily Williams %R ChartEvelo Biosciences Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Evelo Biosciences Inc.

Evelo Biosciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Evelo Biosciences Inc. The current atr is 0.00021038.

Evelo Biosciences Inc Daily Average True Range (ATR) ChartEvelo Biosciences Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Evelo Biosciences Inc. The current obv is 44,651,108.

Evelo Biosciences Inc Daily On-Balance Volume (OBV) ChartEvelo Biosciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Evelo Biosciences Inc. The current mfi is 43.56.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Evelo Biosciences Inc Daily Money Flow Index (MFI) ChartEvelo Biosciences Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Evelo Biosciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-25BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-30MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-12-03STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Evelo Biosciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Evelo Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.781
Ma 20Greater thanMa 500.001
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.001
OpenGreater thanClose0.001
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Evelo Biosciences Inc with someone you think should read this too:
  • Are you bullish or bearish on Evelo Biosciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Evelo Biosciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Evelo Biosciences Inc

I send you an email if I find something interesting about Evelo Biosciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Evelo Biosciences Inc.

Receive notifications about Evelo Biosciences Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.